Human immune responses to SARS-Cov-2 and influenza A virus infection : from myeloid-derived suppressor cells and T cell functions to antibody responses
Author: Yu, Meng
Date: 2022-10-28
Location: J3:06, Ulf von Euler, Eugeniavägen, Karolinska University Hospital, Solna
Time: 9.00
Department: Inst för medicin, Solna / Dept of Medicine, Solna
View/ Open:
Thesis (5.231Mb)
Abstract
Acute respiratory viral infections are the most frequent reason for medical consultations in the world. They cause substantial illness and death every year, especially in young children, the immunocompromised and the elderly, with a large span of disease severity ranging from mild to fatal. This includes both seasonal and pandemic influenza viruses, as well as the newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the ongoing corona virus disease 2019 (COVID-19) pandemic. Disease severity is likely influenced by immune responses directed against the virus, which are critical for clearance and protection but may also cause immunopathogenesis. Thus, understanding the dynamics and function of immune responses during respiratory viral infections is important to better understand and treat the disease.
In this thesis, we studied longitudinal innate and adaptive immune responses in SARS-CoV-2 and influenza A virus (IAV) infected patients to investigate how they associate with and possibly predict disease severity. We also investigated the effects of a genetically engineered anti-viral lectin on the functionality of human immune cells during IAV infection in vitro.
We found that innate monocytic myeloid-derived suppressor cells (M-MDSCs) were expanded in blood of both COVID-19 and influenza patients and strongly associated with disease severity. The MDSCs were functionally intact and potently suppressed T cell proliferation, suggesting a role for M-MDSCs in the dysregulated COVID-19 immune response (Paper I). Next, we observed that patients with moderate or severe COVID-19 disease generated higher levels of SARS-CoV-2-specific antibodies in both blood and airways compared to patients with mild symptoms (Paper II). Furthermore, we revealed the role of activated and virus-specific circulating T follicular helper (cTfh) cells in antibody production in response to SARS-CoV-2 infection.
Importantly, we found that the generation of activated virus-specific cTfh cells was delayed during early infection in patients who already displayed or later developed severe disease. In turn, this was associated with delayed production of virus-neutralizing antibodies needed to combat infection at an early stage and likely contributed to progression to severe COVID-19 disease (Paper III). An aberrant cTfh cell response was also observed in IAV infected patients where older patients displayed delayed appearance of activated cTfh cells compared to younger patients during acute infection. This was associated with lower levels of virus-specific antibodies, which may contribute to poorer clinical outcome in older individuals (Paper IV).
Finally, we found that the genetically engineered banana lectin (BanLec) H84T could inhibit IAV infection yet promote virus-specific CD8 T cell proliferation supported by dendritic cells, pointing to the potential benefit of H84T BanLec as an antiviral therapy (Paper V).
In conclusion, the findings in this thesis provide perspectives on dysregulated immune responses and novel avenues for treatment to combat influenza and COVID-19 more efficiently.
In this thesis, we studied longitudinal innate and adaptive immune responses in SARS-CoV-2 and influenza A virus (IAV) infected patients to investigate how they associate with and possibly predict disease severity. We also investigated the effects of a genetically engineered anti-viral lectin on the functionality of human immune cells during IAV infection in vitro.
We found that innate monocytic myeloid-derived suppressor cells (M-MDSCs) were expanded in blood of both COVID-19 and influenza patients and strongly associated with disease severity. The MDSCs were functionally intact and potently suppressed T cell proliferation, suggesting a role for M-MDSCs in the dysregulated COVID-19 immune response (Paper I). Next, we observed that patients with moderate or severe COVID-19 disease generated higher levels of SARS-CoV-2-specific antibodies in both blood and airways compared to patients with mild symptoms (Paper II). Furthermore, we revealed the role of activated and virus-specific circulating T follicular helper (cTfh) cells in antibody production in response to SARS-CoV-2 infection.
Importantly, we found that the generation of activated virus-specific cTfh cells was delayed during early infection in patients who already displayed or later developed severe disease. In turn, this was associated with delayed production of virus-neutralizing antibodies needed to combat infection at an early stage and likely contributed to progression to severe COVID-19 disease (Paper III). An aberrant cTfh cell response was also observed in IAV infected patients where older patients displayed delayed appearance of activated cTfh cells compared to younger patients during acute infection. This was associated with lower levels of virus-specific antibodies, which may contribute to poorer clinical outcome in older individuals (Paper IV).
Finally, we found that the genetically engineered banana lectin (BanLec) H84T could inhibit IAV infection yet promote virus-specific CD8 T cell proliferation supported by dendritic cells, pointing to the potential benefit of H84T BanLec as an antiviral therapy (Paper V).
In conclusion, the findings in this thesis provide perspectives on dysregulated immune responses and novel avenues for treatment to combat influenza and COVID-19 more efficiently.
List of papers:
I. Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, Björn Österberg, Maximilian Julius Lautenbach, Eric Åhlberg, Ang Lin, Rico Lepzien, Inga Szurgot, Klara Lenart, Fredrika Hellgren, Holden Maecker, Jörgen Sälde, Jan Albert, Niclas Johansson, Max Bell, Karin Loré, Anna Färnert, Anna Smed-Sörensen. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. The Journal of Clinical Investigation. 2021, 131(6):e144734.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck-Jones, Pia C Gubisch, Mert Ödemis, Farangies Ghafoor, Mona Eisele, Klara Lenart, Max Bell, Niclas Johansson, Jan Albert, Jörgen Sälde, Deleah D Pettie, Michael P Murphy, Lauren Carter, Neil P King, Sebastian Ols, Johan Normark, Clas Ahlm, Mattias N Forsell, Anna Färnert, Karin Loré, Anna Smed-Sörensen. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination. The Journal of Clinical Investigation Insight. 2021, 6(22):e151463.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Meng Yu, Afandi Charles, Alberto Cagigi, Wanda Christ, Björn Österberg, Sara Falck-Jones, Lida Azizmohammadi, Eric Åhlberg, Ryan Falck-Jones, Julia Svensson, Mu Nie, Anna Warnqvist, Fredrika Hellgren, Klara Lenart, Rodrigo Arcoverde Cerveira, Sebastian Ols, Gustaf Lindgren, Ang Lin, Holden Maecker, Max Bell, Niclas Johansson, Jan Albert, Christopher Sundling, Paulo Czarnewski, Jonas Klingström, Anna Färnert, Karin Loré, Anna Smed-Sörensen. Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19. [Manuscript]
IV. Meng Yu, Afandi Charles, Björn Österberg, Gustaf Lindgren, Ang Lin, Sara Falck-Jones, Lida Azizmohammadi, Eric Åhlberg, Christopher Sundling, Anna Färnert, Karin Loré, Anna Smed-Sörensen. Older patients display aberrant circulating T follicular helper cell activation and antibodies production in influenza A virus infection. [Manuscript]
V. Meng Yu, Ang Lin, Shuijie Li, Evelyn Covés-Datson, Faezzah Baharom, Karl-Johan Malmberg, Susanne Schlisio, Karin Loré, David Markovitz, Anna Smed-Sörensen. A genetically engineered therapeutic lectin inhibits human influenza A virus infection yet promotes virus-specific CD8 T cell proliferation by dendritic cells. [Manuscript]
I. Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, Björn Österberg, Maximilian Julius Lautenbach, Eric Åhlberg, Ang Lin, Rico Lepzien, Inga Szurgot, Klara Lenart, Fredrika Hellgren, Holden Maecker, Jörgen Sälde, Jan Albert, Niclas Johansson, Max Bell, Karin Loré, Anna Färnert, Anna Smed-Sörensen. Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity. The Journal of Clinical Investigation. 2021, 131(6):e144734.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck-Jones, Pia C Gubisch, Mert Ödemis, Farangies Ghafoor, Mona Eisele, Klara Lenart, Max Bell, Niclas Johansson, Jan Albert, Jörgen Sälde, Deleah D Pettie, Michael P Murphy, Lauren Carter, Neil P King, Sebastian Ols, Johan Normark, Clas Ahlm, Mattias N Forsell, Anna Färnert, Karin Loré, Anna Smed-Sörensen. Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination. The Journal of Clinical Investigation Insight. 2021, 6(22):e151463.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Meng Yu, Afandi Charles, Alberto Cagigi, Wanda Christ, Björn Österberg, Sara Falck-Jones, Lida Azizmohammadi, Eric Åhlberg, Ryan Falck-Jones, Julia Svensson, Mu Nie, Anna Warnqvist, Fredrika Hellgren, Klara Lenart, Rodrigo Arcoverde Cerveira, Sebastian Ols, Gustaf Lindgren, Ang Lin, Holden Maecker, Max Bell, Niclas Johansson, Jan Albert, Christopher Sundling, Paulo Czarnewski, Jonas Klingström, Anna Färnert, Karin Loré, Anna Smed-Sörensen. Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19. [Manuscript]
IV. Meng Yu, Afandi Charles, Björn Österberg, Gustaf Lindgren, Ang Lin, Sara Falck-Jones, Lida Azizmohammadi, Eric Åhlberg, Christopher Sundling, Anna Färnert, Karin Loré, Anna Smed-Sörensen. Older patients display aberrant circulating T follicular helper cell activation and antibodies production in influenza A virus infection. [Manuscript]
V. Meng Yu, Ang Lin, Shuijie Li, Evelyn Covés-Datson, Faezzah Baharom, Karl-Johan Malmberg, Susanne Schlisio, Karin Loré, David Markovitz, Anna Smed-Sörensen. A genetically engineered therapeutic lectin inhibits human influenza A virus infection yet promotes virus-specific CD8 T cell proliferation by dendritic cells. [Manuscript]
Institution: Karolinska Institutet
Supervisor: Smed-Sörensen, Anna
Co-supervisor: Loré, Karin; Färnert, Anna
Issue date: 2022-10-03
Rights:
Publication year: 2022
ISBN: 978-91-8016-797-0
Statistics
Total Visits
Views | |
---|---|
Human ... | 448 |
Total Visits Per Month
March 2024 | April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | |
---|---|---|---|---|---|---|---|
Human ... | 11 | 3 | 6 | 8 | 5 | 9 | 1 |
File Visits
Views | |
---|---|
Thesis_Meng_Yu.pdf | 678 |
Meng Yu Kappan.pdf | 2 |
Top country views
Views | |
---|---|
Sweden | 116 |
United States | 66 |
Ireland | 36 |
Germany | 34 |
United Kingdom | 13 |
France | 11 |
Australia | 10 |
Canada | 9 |
China | 9 |
South Korea | 7 |
Top cities views
Views | |
---|---|
Stockholm | 19 |
Dublin | 13 |
Sundbyberg | 10 |
Uppsala | 8 |
Gothenburg | 7 |
Malmo | 6 |
Solna | 6 |
Ashburn | 5 |
Hanoi | 5 |
Bromma | 4 |